Article Details

Procaps Group Faces Nasdaq Delisting Risk Over Delayed 2023 Financial Filing | PROC Stock News

Retrieved on: 2024-11-15 23:16:59

Tags for this article:

Click the tags to see associated articles and topics

Procaps Group Faces Nasdaq Delisting Risk Over Delayed 2023 Financial Filing | PROC Stock News. View article details on hiswai:

Excerpt

Procaps develops, manufactures, and markets over-the-counter (OTC) pharmaceutical products, prescription pharmaceutical drugs (Rx), nutritional ...

Article found on: www.stocktitan.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up